
News|Articles|June 29, 2026
AAP updates guidance on pediatric iron deficiency screening and treatment
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Benjamin P. Saylor
New AAP guidance recommends age-specific iron deficiency screening, updated ferritin thresholds, and simplified treatment strategies for children.
Advertisement
Advertisement
Iron deficiency remains one of the most common nutritional deficiencies among children and adolescents in the United States, prompting the American Academy of Pediatrics (AAP) to issue updated recommendations on prevention, screening, diagnosis, and treatment. The new clinical report expands previous guidance by addressing care across infancy through adolescence and incorporates emerging evidence on laboratory evaluation, oral iron dosing, and the role of intravenous iron therapy.
Related to this article

Melissa Wallach, MD, FAAP, discusses what pediatricians should know about updated screening, supplementation, and treatment recommendations for iron deficiency.

This FAQ breaks down the AAP's newest COVID-19, RSV, and influenza recommendations for clinicians who want a quick refresher on what changed for the 2026-2027 season.

The AAP's 2026-2027 policy recommends universal vaccination for infants 6-23 months and a risk-based single dose for children 2-18 years.

AAP guidance expands RSV immunization eligibility for children aged 8 through 19 months at high risk of severe disease.

The AAP's updated clinical report revises screening timelines, ferritin thresholds, and treatment protocols for pediatric iron deficiency and iron deficiency anemia.

The AAP recommends annual flu vaccination for all children aged 6 months and older and updates antiviral guidance for the 2026–2027 season.

FDA approved levacetylleucine (Aqneursa) for ataxia in ataxia-telangiectasia, the first therapy for the disease, in patients 15 kg or heavier.
Advertisement
Advertisement

